A detailed history of Michael S. Ryan, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Michael S. Ryan, Inc. holds 3,817 shares of MRK stock, worth $297,726. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,817
Previous 3,923 2.7%
Holding current value
$297,726
Previous $390,000 12.31%
% of portfolio
0.25%
Previous 0.27%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025

SELL
$83.01 - $101.02 $8,799 - $10,708
-106 Reduced 2.7%
3,817 $342,000
Q3 2024

Oct 11, 2024

BUY
$111.15 - $128.97 $333 - $386
3 Added 0.08%
3,923 $445 Million
Q2 2024

Jul 01, 2024

SELL
$123.8 - $132.96 $58,186 - $62,491
-470 Reduced 10.71%
3,920 $485 Million
Q1 2024

Apr 01, 2024

SELL
$113.24 - $131.95 $18,458 - $21,507
-163 Reduced 3.58%
4,390 $579 Million
Q3 2023

Nov 01, 2023

BUY
$102.95 - $114.33 $18,428 - $20,465
179 Added 4.09%
4,553 $468 Million
Q2 2023

Jul 26, 2023

BUY
$108.61 - $118.38 $475,060 - $517,794
4,374 New
4,374 $500 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $198B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Michael S. Ryan, Inc. Portfolio

Follow Michael S. Ryan, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Michael S. Ryan, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Michael S. Ryan, Inc. with notifications on news.